A Controlled Trial of Bismuth Subsalicylate in Infants with Acute Watery Diarrheal Disease

New England Journal of Medicine

Volumn 328, Issue 23, 1993, Pages 1653-1658

  Figueroa Quintanilla, Dante ^a   Salazar Lindo, Eduardo ^b   Sack, R Bradley ^c   Leon Barua, Raul ^b   Sarabia Arce, Silvana ^b   Campos Sanchez, Miguel ^b   Eyzaguirre Maccan, Eduardo ^b  

^a INSTITUTO NACIONAL DE SALUD DEL NIÑO   (Peru)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISMUTH SALICYLATE;

ACUTE DIARRHEA; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG BLOOD LEVEL; DRUG EFFICACY; FECES CULTURE; FEEDING; HOSPITALIZATION; HUMAN; INFANT; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; REHYDRATION;

AMERICAS; DEVELOPING COUNTRIES; DIARRHEA; DIARRHEA, INFANTILE; DISEASES; DOUBLE-BLIND STUDIES; DRUGS; LATIN AMERICA; PERU; RESEARCH METHODOLOGY; SOUTH AMERICA; STUDIES; TREATMENT;

ACUTE DISEASE; BISMUTH; BODY WEIGHT; CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; DIARRHEA, INFANTILE; DOUBLE-BLIND METHOD; FLUID THERAPY; HUMAN; INFANT; MALE; MULTIVARIATE ANALYSIS; ORGANOMETALLIC COMPOUNDS; SALICYLATES; SUPPORT, NON-U.S. GOV'T;

EID: 0027195248     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199306103282301     Document Type: Article

References (26)

1. Bierer DW Bismuth subsalicylate: history, chemistry, and safety. Rev Infect Dis 1990; 12: Suppl 1: S3-S8
2. DuPont HL, Ericsson CD, Johnson PC, de la Cabada FJ Use of bismuth subsalicylate for the prevention of travelers' diarrhea. Rev Infect Dis 1990; 12: Suppl 1: S64-S67
3. DuPont HL, Sullivan P, Pickering LK, Haynes G, Ackerman PB Symptomatic treatment of diarrhea with bismuth subsalicylate among students attending a Mexican university. Gastroenterology 1977; 73:715-718
4. Steinhoff MC, Douglas RG Jr, Greenberg HB, Callahan DR Bismuth subsalicylate therapy of viral gastroenteritis. Gastroenterology 1980; 78:1495-1499
5. Gryboski JD, Kocoshis S Effect of bismuth subsalicylate on chronic diarrhea in childhood: a preliminary report. Rev Infect Dis 1990; 12: Suppl 1: S36-S40
6. Soriano-Brucher H, Avendano P, O'Ryan M, Bismuth subsalicylate in the treatment of acute diarrhea in children: a clinical study. Pediatrics 1991; 87:18-27
7. Hamill PV, Drizd TA, Johnson CL, Reed RB, Roche AF, Moore WM Physical growth: National Center for Health Statistics percentiles. Am J Clin Nutr 1979; 32:607-629
8. Brown KH, Gastanaduy AS, Saavedra JM, Effect of continued oral feeding on clinical and nutritional outcomes of acute diarrhea in children. J Pediatr 1988; 112:191-200
9. The treatment and prevention of acute diarrhoea: practical guidelines. 2nd ed. Geneva: World Health Organization, 1989.
10. Pazzaglia G, Sack RB, Salazar E, High frequency of coinfecting enteropathogens in Aeromonas-associated diarrhea of hospitalized Peruvian infants. J Clin Microbiol 1991; 29:1151-1156
11. Manual for laboratory investigation of acute enteric infections. Geneva: World Health Organization, 1983.
12. Toxicology – poisons and drugs. In: Bauer JD, Toro G, Ackermann PG, eds. Bray's clinical laboratory methods. St. Louis: C.V. Mosby, 1962:511-32.
13. Froomes PR, Wan AT, Harrison PM, McLean AJ Improved assay for bismuth in biological samples by atomic absorption spectrophotometry with hydride generation. Clin Chem 1988; 34:382-384
14. Survival analysis. In: Friedman LM, Furberg CD, DeMets DL. Fundamentals of clinical trials. 2nd ed. Littleton, Mass.: PSG Publishing, 1985:191-211.
15. Peto R, Pike MC, Armitage P, Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35:1-39
16. Hillemand P, Palliere M, Laquais B, Bouvet P Traitement bismuthique et bismuthemie. Sem Hop Paris 1977; 53:1663-1669
17. Burns R, Thomas DW, Barron VJ Reversible encephalopathy possibly associated with bismuth subgallate ingestion. BMJ 1974; 1:220-223
18. Lagier G Encephalopathies bismuthiques: situation dans les pays autres que la France. Therapie 1980; 35:315-317
19. Ericsson CD, Tannenbaum C, Charles TT Antisecretory and antiinflammatory properties of bismuth subsalicylate. Rev Infect Dis 1990; 12: Suppl 1: S16-S20
20. Ericsson CD, Evans DG, DuPont HL, Evans DJ Jr, Pickering LK Bismuth subsalicylate inhibits activity of crude toxins of Escherichia coli and Vibrio cholerae. J Infect Dis 1977; 136:693-696
21. Manhart MD In vitro antimicrobial activity of bismuth subsalicylate and other bismuth salts. Rev Infect Dis 1990; 12: Suppl 1: S11-S15
22. Graham DY, Estes MK, Gentry LO Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers. Gastroenterology 1983; 85:1017-1022
23. Ward RL, Sander DS, Knowlton DR In vitro activities of bismuth salts against rotaviruses and other enteric viruses. Antimicrob Agents Chemother 1985; 27:306-308
24. DuPont HL, Sullivan P, Evans DG, Prevention of traveler's diarrhea (emporiatric enteritis): prophylactic administration of subsalicylate bismuth. JAMA 1980; 243:237-241
25. Steffen R, Mathewson JJ, Ericsson CD, Travelers' diarrhea in West Africa and Mexico: fecal transport systems and liquid bismuth subsalicylate for self-therapy. J Infect Dis 1988; 157:1008-1013
26. The rational use of drugs in the management of acute diarrhoea in children. Geneva: World Health Organization, 1990.